Format
Sort by

Send to

Choose Destination

Search results

Items: 19

1.

Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma.

Parker WP, Lohse CM, Zaid HB, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.

Urol Oncol. 2016 Sep 26. pii: S1078-1439(16)30247-2. doi: 10.1016/j.urolonc.2016.08.013. [Epub ahead of print]

PMID:
27687543
2.

Patterns of Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: Unique Identification of Sites of Recurrence Impacting Clinical Management.

Parker WP, Davis BJ, Park SS, Olivier K, Choo CR, Nathan MA, Lowe VJ, Welch TJ, Zaid HB, Sobol II, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes JR, Kwon ED.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S112. doi: 10.1016/j.ijrobp.2016.06.276. No abstract available.

PMID:
27675554
3.

Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease.

Parker WP, Davis BJ, Park SS, Olivier KR, Choo R, Nathan MA, Lowe VJ, Welch TJ, Evans JD, Harmsen WS, Zaid HB, Sobol I, Moreira DM, Haloi R, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes RJ, Kwon ED.

Eur Urol. 2016 Sep 3. pii: S0302-2838(16)30528-0. doi: 10.1016/j.eururo.2016.08.055. [Epub ahead of print]

PMID:
27597240
4.

Characterization of perioperative infection risk among patients undergoing radical cystectomy: Results from the national surgical quality improvement program.

Parker WP, Tollefson MK, Heins CN, Hanson KT, Habermann EB, Zaid HB, Frank I, Thompson RH, Boorjian SA.

Urol Oncol. 2016 Aug 5. pii: S1078-1439(16)30164-8. doi: 10.1016/j.urolonc.2016.07.001. [Epub ahead of print]

PMID:
27503783
5.

Outcomes following complete surgical metastasectomy for patients with metastatic renal cell carcinoma: a systematic review and meta-analysis.

Zaid HB, Parker WP, Safdar NS, Gershman B, Erwin PJ, Murad MH, Boorjian SA, Costello BA, Thompson RH, Leibovich BC.

J Urol. 2016 Jul 26. pii: S0022-5347(16)30923-5. doi: 10.1016/j.juro.2016.07.079. [Epub ahead of print]

PMID:
27473875
6.

Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma.

Gakis G, Efstathiou JA, Daneshmand S, Keegan KA, Clayman RH, Hrbacek J, Ali-El-Dein B, Zaid HB, Schubert T, Mischinger J, Todenhöfer T, Galland S, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Morgan TM.

Urol Int. 2016;97(2):134-41. doi: 10.1159/000448335. Epub 2016 Jul 28.

PMID:
27462702
7.

Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with C-11 Choline PET and Multiparametric MRI.

Sobol I, Zaid HB, Haloi R, Mynderse LA, Froemming AT, Lowe VJ, Davis BJ, Kwon ED, Karnes RJ.

J Urol. 2016 Jul 20. pii: S0022-5347(16)30916-8. doi: 10.1016/j.juro.2016.07.073. [Epub ahead of print]

PMID:
27449262
8.

Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients.

Parker WP, Cheville JC, Frank I, Zaid HB, Lohse CM, Boorjian SA, Leibovich BC, Houston Thompson R.

Eur Urol. 2016 Jun 7. pii: S0302-2838(16)30242-1. doi: 10.1016/j.eururo.2016.05.034. [Epub ahead of print]

PMID:
27287995
9.

Risk Factors and Microbial Distribution of Urinary Tract Infections Following Radical Cystectomy.

Parker WP, Toussi A, Tollefson MK, Frank I, Thompson RH, Zaid HB, Thapa P, Boorjian SA.

Urology. 2016 Aug;94:96-101. doi: 10.1016/j.urology.2016.03.049. Epub 2016 Apr 25.

PMID:
27125878
10.

Efficacy and Safety of Intraoperative Tranexamic Acid Infusion for Reducing Blood Transfusion During Open Radical Cystectomy.

Zaid HB, Yang DY, Tollefson MK, Frank I, Winters JL, Thapa P, Parker WP, Thompson RH, Karnes RJ, Boorjian SA.

Urology. 2016 Jun;92:57-62. doi: 10.1016/j.urology.2016.02.044. Epub 2016 Mar 8.

PMID:
26968489
11.

Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma.

Gakis G, Morgan TM, Efstathiou JA, Keegan KA, Mischinger J, Todenhoefer T, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Daneshmand S.

World J Urol. 2016 Jan;34(1):97-103. doi: 10.1007/s00345-015-1583-7. Epub 2015 May 17.

PMID:
25981402
12.

Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.

Gakis G, Morgan TM, Daneshmand S, Keegan KA, Todenhöfer T, Mischinger J, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Efstathiou JA.

Ann Oncol. 2015 Aug;26(8):1754-9. doi: 10.1093/annonc/mdv230. Epub 2015 May 12.

13.

Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States.

Keegan KA, Zaid HB, Patel SG, Chang SS.

Curr Urol Rep. 2014 Apr;15(4):394. doi: 10.1007/s11934-014-0394-5. Review.

14.

Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides.

Reardon ZD, Patel SG, Zaid HB, Stimson CJ, Resnick MJ, Keegan KA, Barocas DA, Chang SS, Cookson MS.

Eur Urol. 2015 Jan;67(1):165-70. doi: 10.1016/j.eururo.2014.01.009. Epub 2014 Jan 23.

15.

Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: results from the National Cancer Database.

Zaid HB, Patel SG, Stimson CJ, Resnick MJ, Cookson MS, Barocas DA, Chang SS.

Urology. 2014 Jan;83(1):75-80. doi: 10.1016/j.urology.2013.07.072. Epub 2013 Nov 11.

PMID:
24231210
16.

Locoregional small cell carcinoma of the bladder: clinical characteristics and treatment patterns.

Patel SG, Stimson CJ, Zaid HB, Resnick MJ, Cookson MS, Barocas DA, Chang SS.

J Urol. 2014 Feb;191(2):329-34. doi: 10.1016/j.juro.2013.09.009. Epub 2013 Sep 12.

PMID:
24036236
17.
18.

Outcomes of active surveillance for men with intermediate-risk prostate cancer.

Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR.

J Clin Oncol. 2011 Jan 10;29(2):228-34. doi: 10.1200/JCO.2010.31.4252. Epub 2010 Nov 29.

19.

Image of the month--quiz case. Gastric duplication cyst.

Zaid HB, Rhee SJ, Hirose S, Mackenzie TC.

Arch Surg. 2010 Oct;145(10):1019, 1020. doi: 10.1001/archsurg.2010.206-a. No abstract available.

PMID:
20956774
Items per page

Supplemental Content

Write to the Help Desk